(Q33539675)

27 July 2017

1 reference

title

Evolving perspectives in contralateral breast cancer (English)

1 reference

27 July 2017

Dawson LA

1

0 references

author name string

Chow E

series ordinal

2

1 reference

27 July 2017

Goss PE

series ordinal

3

1 reference

27 July 2017

publication date

1 December 1998

1 reference

European Journal of Cancer

27 July 2017

published in

1 reference

27 July 2017

volume

34

1 reference

27 July 2017

issue

13

1 reference

27 July 2017

page(s)

2000-2009

1 reference

Bilateral primary breast cancer: a prospective study of disease incidence.

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Age at first primary as a determinant of the incidence of bilateral breast cancer. Cumulative and relative risks in a population-based case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

BILATERAL PRIMARY BREAST CANCER; A PROSPECTIVE CLINICOPATHOLOGICAL STUDY.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Risk of contralateral breast cancer in Denmark 1943-80.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Contralateral breast cancer: clinical characteristics and impact on prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

The relation between survival and age at diagnosis in breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Bilateral breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Bilateral breast cancer: early detection with mammography.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Contralateral breast cancer: annual incidence and risk parameters.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Annual hazard rates of recurrence for breast cancer after primary therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Intensive Diagnostic Follow-up After Treatment of Primary Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. The GIVIO Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Incidence of bilateral tumours in a population-based series of breast-cancer patients. I. Two approaches to an epidemiological analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Risk factors predicting the incidence of second primary breast cancer among women diagnosed with a first primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Survival in bilateral breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Survival of first and second primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Second primary cancers of the breast: incidence and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Consecutive primary carcinomas of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Evaluation of the contralateral breast. The role of biopsy at the time of treatment of primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Bilateral breast cancer: biopsy of the opposite breast

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Bilateral breast cancer. Risk reduction by contralateral biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Selective biopsy of the opposite breast

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Bilateral Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Managing the remaining breast

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Experience with opposite breast biopsy in patients with operable breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

The contralateral breast in ipsilateral breast carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Arguments against routine contralateral mastectomy or undirected biopsy for invasive lobular breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Synchronous, bilateral mastectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Contralateral cancerous breast lesions in women with clinical invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4). XI. Bilateral breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Breast cancer: a 21 year experience with conservative surgery and radiation.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Contralateral breast cancer and other second malignancies in patients treated by breast-conserving therapy with radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Clinical epidemiology of bilateral breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Bilateral primary breast cancer in patients treated with adjuvant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Bilateral carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

The genetic epidemiology of second primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Bilaterality in familial breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Risk of contralateral breast cancer: associations with factors related to initial breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Cancer in the contralateral breast after radiotherapy for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Risk of contralateral breast cancer. Associations with histologic, clinical, and therapeutic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Incidence of female breast cancer among atomic bomb survivors, 1950-1985

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Breast cancer in patients irradiated for Hodgkin's disease: a clinical and pathologic analysis of 45 events in 37 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Susceptibility genes for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Breast cancer survival in BRCA1 carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Absence of linkage to the ataxia telangiectasia locus in familial breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Studies of cancer and radiation dose among atomic bomb survivors. The example of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Breast cancer following irradiation of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Breast cancer in women with scoliosis exposed to multiple diagnostic x rays

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Breast carcinoma in young women previously treated for Hodgkin disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Mammary carcinoma developing after radiotherapy and chemotherapy for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Breast cancer after Hodgkin's disease in two sisters.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Breast cancer after treatment of Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Bilateral breast cancer after cured Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Low-dose radiation--a cause of breast cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Radiation-induced sarcomas of the chest wall

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Breast-conserving surgery with radiation therapy for operable mammary carcinoma: a 25-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Breast neoplasms in women treated with x-rays for acute postpartum mastitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Bilateral breast cancer in patients with initial stage I and II disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Adjuvant radiotherapy and risk of contralateral breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Prognostic factors for metachronous contralateral breast cancer: a comparison of the linear Cox regression model and its artificial neural network extension.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Estrogen and progesterone receptor content in bilateral breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Graphs to estimate an individualized risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

New Perspective on Cancer of the Contralateral Breast: A Marker for Assessing Tamoxifen as a Preventive Agent

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Contralateral primary tumors in breast cancer patients in a randomized trial of adjuvant tamoxifen therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Results of the Cancer Research Campaign Adjuvant Trial for Perioperative Cyclophosphamide and Long-Term Tamoxifen in Early Breast Cancer reported at the tenth year of follow-up. Cancer Research Campaign Breast Cancer Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Impact of radiation therapy and/or chemotherapy on the risk for a second malignancy after breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

A study of the epidemiology of cancer of the breast. II. The influence of hysterectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Breast Cancer in Relation to Nursing and Menopausal History2

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Subcutaneous mastectomy is not a prophylaxis against carcinoma of the breast: opinion or knowledge?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Decision analysis--effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

The practice of breast self-examination results in the earlier detection and better clinical course of Japanese women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Breast self-examination programmes in the trial of early detection of breast cancer: ten year findings

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Breast self-examination and survival from breast cancer: a prospective follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Has monitoring of the contralateral breast improved the prognosis in patients treated for primary breast cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Prognostic impact of early detection of contralateral primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

The contribution of routine follow-up mammography to an early detection of asynchronous contralateral breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Screening: assessment of current studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Breast cancer incidence and mortality in the breast cancer detection demonstration project [published errtum appears in J Natl Cancer Inst 1989 Oct 4;81(19):1513]

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Effect on breast cancer mortality of biennial mammographic screening of women under age 50

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Value of CA 15.3 in breast cancer and comparison with CEA and TPA: a study of specificity in disease-free follow-up patients and sensitivity in patients at diagnosis of the first metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

New mucin-like cancer-associated antigens (CA M 26, CA M 29 and CA 549) and a new proliferation marker (TPS) in patients with primary or advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

[CA 15-3 and CEA as tumor markers in the diagnosis of the recurrence of breast cancer]

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

CA 15.3 determination in patients with breast cancer: clinical utility for the detection of distant metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Tamoxifen rechallenge: response to tamoxifen following relapse after adjuvant chemohormonal therapy for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

The value of high dose tamoxifen in postmenopausal breast cancer patients progressing on standard doses: A pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Endocrine therapy for advanced breast cancer: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

Duration and reintroduction of adjuvant chemotherapy for node-positive premenopausal breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900208-1

7 January 2021

10.1016/S0959-8049(98)00208-1

Identifiers

DOI

1 reference

27 July 2017

1 reference